E Fund Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

E Fund Management Co., Ltd.

$1.8 Billion
Q2 2024

A detailed history of E Fund Management Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 2,339 shares of REGN stock, worth $2.43 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,339

Previous 1,693 38.16%

Holding current value

$2.43 Million

Previous $1.63 Million 50.89%

% of portfolio

0.14%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $570,547 - $691,988	646 Added 38.16%	2,339 $2.46 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $106,517 - $117,215	-118 Reduced 6.52%	1,693 $1.63 Million
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $17,053 - $19,397	-22 Reduced 1.2%	1,811 $1.59 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $78,246 - $95,413	113 Added 6.57%	1,833 $1.51 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $59,502 - $70,579	-85 Reduced 4.71%	1,720 $1.24 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $87,102 - $105,852	-128 Reduced 6.62%	1,805 $1.48 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $141,883 - $154,044	-201 Reduced 9.42%	1,933 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $28,124 - $35,491	-49 Reduced 2.24%	2,134 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $205,631 - $277,065	375 Added 20.74%	2,183 $1.29 Million
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $83,911 - $98,478	141 Added 8.46%	1,808 $1.26 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $2,717 - $3,354	5 Added 0.3%	1,667 $1.05 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $42,478 - $50,391	-74 Reduced 4.26%	1,662 $1.01 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $775,523 - $951,675	1,736 New	1,736 $821,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History